Prot# NU 03N2: A Phase II Trial of Induction Chemotherapy With Cisplatin and Docetaxel Followed by Radiotherapy Plus Cisplatin in Patients With Locally Advanced Unresectable Head and Neck Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date5/27/0411/11/11

Funding

  • Aventis Pharmaceuticals Inc. (NU 03N2)